Sectors
CLRB
Cellectar Biosciences, Inc.
2.54
12 x 2.52
22 x 2.54
bid
ask
-
0.04
1.36%
09:54 AM
timesize
| Ytd | -13.73% | |
| 1y | -51.06% |
2.53
day range
2.54
2.20
52 week range
6.52
| Open | 2.54 | Prev Close | 2.58 | Low | 2.53 | High | 2.54 | Mkt Cap | 8.24M |
| Vol | 19.02K | Avg Vol | 1.07M | EPS | -6.66 | P/E | -0.39 | Forward P/E | -0.10 |
| Beta | 0.55 | Short Ratio | 8.34 | Inst. Own | 34.55% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 2.75 | 200-d Avg | 3.19 | 1yr Est | 5.67 |
| Income Statement | |||
| Operating Expenses | 5.79M | ||
| Research and Development Expense | 3.01M | ||
| Selling, General and Administrative Expense | 2.79M | ||
| Operating Income | -5.79M | ||
| Net Income | -5.65M | ||
| Net Income Common Stock | -5.65M | ||
| Net Income Common Stock (USD) | -5.65M | ||
| Consolidated Income | -5.65M | ||
| Earnings per Basic Share | -1.33 | ||
| Earnings per Basic Share (USD) | -1.33 | ||
| Earnings per Diluted Share | -1.33 | ||
| Earning Before Interest & Taxes (EBIT) | -5.65M | ||
| Earning Before Interest & Taxes (USD) | -5.65M | ||
| Weighted Average Shares | 4.24M | ||
| Weighted Average Shares Diluted | 4.24M | ||
| Balance Sheet | |||
| Cash and Equivalents | 8.35M | ||
| Cash and Equivalents (USD) | 8.35M | ||
| Current Assets | 9.27M | ||
| Property, Plant & Equipment Net | 1.82M | ||
| Total Assets | 11.12M | ||
| Total Debt | 1.53M | ||
| Current Liabilities | 4.87M | ||
| Debt Non-Current | 1.53M | ||
| Total Liabilities | 6.40M | ||
| Accumulated Retained Earnings (Deficit) | -274.79M | ||
| Shareholders Equity | 3.34M | ||
| Shareholders Equity (USD) | 3.34M | ||
| Assets Non-Current | 1.85M | ||
| Total Debt (USD) | 1.53M | ||
| Liabilities Non-Current | 1.53M | ||
| Trade and Non-Trade Payables | 4.72M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | -110.02K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -4.85M | ||
| Capital Expenditure | -3.38K | ||
| Net Cash Flow from Investing | -3.38K | ||
| Net Cash Flow from Operations | -4.85M | ||
| Share Based Compensation | 451.87K | ||